Structured evidence table for Pea Protein Satiety Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pea Protein Satiety Meta-Analysis | to manage postprandial glycaemic excursions, such as hyperglycaemia— a key risk factor for cardiometabolic complications. | 2 | Elbira Arig (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study |
| Pea Protein Satiety Meta-Analysis | Elevated postprandial glucose levels are consistently associated with increased cardiovascular risk, even in normoglycaemic individuals []. | 2 | Elbira Arig (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study |
| Pea Protein Satiety Meta-Analysis | found that whey protein preloads significantly reduced peak glucose (− 0.62 mmol/L) and 2-hour iAUC (− 39.8 mmol·min/L), particularly with doses ≥ 20 g taken 15–30 min before a carbohydrate-rich meal []. | 2 | Elbira Arig (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study |
| Pea Protein Satiety Meta-Analysis | 1 3 4 The increasing prevalence of metabolic disorders and cardiovascular diseases presents significant challenges to global health [–], highlighting the need for cost-effective dietary interventions e.g. | 2 | Elbira Arig (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study |
| Pea Protein Satiety Meta-Analysis | According to the internationally used definition, MetS is characterized by having at least three out of several possible risk factors, including high blood pressure, hypertriglyceridemia, low levels of HDL cholesterol, elevated fasting glucose, and central obesity (). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Satiety Meta-Analysis | α p p 6 7 9 9 10 6 High levels of TNF-, IL-6, and CRP are associated with insulin resistance, endothelial dysfunction, and atherogenesis (,,). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Satiety Meta-Analysis | Such increases appear to be closely linked to MetS, type 2T2DM, and CVD risk (,). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Satiety Meta-Analysis | 1 1 The metabolic syndrome (MetS), one of the most significant public health problems of the 21st century, is characterized by central obesity, insulin resistance, hypertension, and dyslipidemia. | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
Source documents